Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 10
287
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Iranian plant Eremurus persicus: an overview of botany, traditional uses, phytochemistry and pharmacology

&
Pages 2692-2705 | Received 09 Feb 2021, Accepted 09 Apr 2021, Published online: 28 Apr 2021
 

Abstract

Eremurus persicus (Jaub. & Spach) Boiss. commonly known as "Serish" is a valuable ornamental plant with culinary uses and also utilized in traditional medicine for treating Gastrointestinal diseases. This comprehensive study was performed to investigate the pharmacological and biological effects of E. persicus and the compounds identified and isolated from it in order to encourage researchers to study it further. Despite the few number of studies on the ethnopharmacology of the plant E. persicus, however studies conducted on either crude extracts, solvent fractions or isolated pure compounds from E. persicus a varied range of biological effects comprising antibacterial, anti-fungal, anti-diabetic and etc. have reported. Phytochemical analysis of different parts of E. persicus unveiled 52 phytochemicals. However, the toxicity of this plant and its ethnopharmacological claims should be thoroughly investigated.

Graphical Abstract

Acknowledgments

Our, authors, thank God Almighty for the success of in completing this review article.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research received no external funding.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.